// App-Quantinova.ai

323 : Role of Mir-30e in Multiple Myeloma Cells Resistance to Lenalidomide and Bortezomib

Researchers

Presenter

  • Kathy Gratton

Principal Investigators

  • Li Ren

  • Jordan Johnson

  • Jiri Slaby

  • Peter Duggan

  • Douglas A. Stewart

  • Nizar J. Bahlis

Medical Centers

  • University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Annexin V

  • X-Box Binding Protein 1

Drug/Treatment

  • Lenalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved